

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.85255947 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.60782400 |
| 3 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.38959446 |
| 4 | cellular response to ethanol (GO:0071361) | 3.38017554 |
| 5 | neural tube formation (GO:0001841) | 3.24383102 |
| 6 | oligosaccharide catabolic process (GO:0009313) | 3.10317356 |
| 7 | chondrocyte development (GO:0002063) | 3.04940257 |
| 8 | response to pheromone (GO:0019236) | 2.97672232 |
| 9 | presynaptic membrane organization (GO:0097090) | 2.93656147 |
| 10 | axon ensheathment in central nervous system (GO:0032291) | 2.93345586 |
| 11 | central nervous system myelination (GO:0022010) | 2.93345586 |
| 12 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.91285470 |
| 13 | limb bud formation (GO:0060174) | 2.90760135 |
| 14 | interkinetic nuclear migration (GO:0022027) | 2.90263456 |
| 15 | nerve growth factor signaling pathway (GO:0038180) | 2.89247918 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 2.87412729 |
| 17 | collagen fibril organization (GO:0030199) | 2.81669042 |
| 18 | nucleus localization (GO:0051647) | 2.80950334 |
| 19 | asymmetric protein localization (GO:0008105) | 2.74274357 |
| 20 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.72003229 |
| 21 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.71952922 |
| 22 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.70974981 |
| 23 | response to lipoprotein particle (GO:0055094) | 2.70330319 |
| 24 | proline transport (GO:0015824) | 2.67878329 |
| 25 | prostate gland growth (GO:0060736) | 2.67282182 |
| 26 | intraciliary transport (GO:0042073) | 2.66129414 |
| 27 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.65891344 |
| 28 | relaxation of cardiac muscle (GO:0055119) | 2.65261498 |
| 29 | pericardium development (GO:0060039) | 2.63171991 |
| 30 | negative regulation of axon guidance (GO:1902668) | 2.61904991 |
| 31 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.60853679 |
| 32 | membrane raft organization (GO:0031579) | 2.60832630 |
| 33 | platelet dense granule organization (GO:0060155) | 2.60395606 |
| 34 | negative regulation of mast cell activation (GO:0033004) | 2.59139461 |
| 35 | cell adhesion mediated by integrin (GO:0033627) | 2.54639681 |
| 36 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.53742946 |
| 37 | iron ion import (GO:0097286) | 2.53686706 |
| 38 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.53460248 |
| 39 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.53166289 |
| 40 | branching involved in prostate gland morphogenesis (GO:0060442) | 2.52483166 |
| 41 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.52215034 |
| 42 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.50326215 |
| 43 | I-kappaB phosphorylation (GO:0007252) | 2.50118759 |
| 44 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.49743041 |
| 45 | cilium organization (GO:0044782) | 2.49149454 |
| 46 | ER overload response (GO:0006983) | 2.47817033 |
| 47 | protein K11-linked deubiquitination (GO:0035871) | 2.47281319 |
| 48 | retinal ganglion cell axon guidance (GO:0031290) | 2.46857520 |
| 49 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.46256109 |
| 50 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.45612561 |
| 51 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.45612561 |
| 52 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.45612561 |
| 53 | cilium assembly (GO:0042384) | 2.44793236 |
| 54 | phospholipid translocation (GO:0045332) | 2.44128881 |
| 55 | lipid translocation (GO:0034204) | 2.44128881 |
| 56 | cilium morphogenesis (GO:0060271) | 2.44058520 |
| 57 | establishment of nucleus localization (GO:0040023) | 2.43661299 |
| 58 | regulation of heat generation (GO:0031650) | 2.42636518 |
| 59 | protein localization to cilium (GO:0061512) | 2.42612192 |
| 60 | glycosphingolipid catabolic process (GO:0046479) | 2.42196231 |
| 61 | photoreceptor cell differentiation (GO:0046530) | 2.41451779 |
| 62 | eye photoreceptor cell differentiation (GO:0001754) | 2.41451779 |
| 63 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.41382634 |
| 64 | retina layer formation (GO:0010842) | 2.40894128 |
| 65 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.40717387 |
| 66 | inner ear receptor stereocilium organization (GO:0060122) | 2.40211140 |
| 67 | ganglioside metabolic process (GO:0001573) | 2.39938281 |
| 68 | embryonic foregut morphogenesis (GO:0048617) | 2.38148348 |
| 69 | regulation of sarcomere organization (GO:0060297) | 2.38058588 |
| 70 | wound healing, spreading of epidermal cells (GO:0035313) | 2.37528082 |
| 71 | regulation of mononuclear cell migration (GO:0071675) | 2.37032188 |
| 72 | membrane assembly (GO:0071709) | 2.36619572 |
| 73 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.35678814 |
| 74 | establishment of protein localization to Golgi (GO:0072600) | 2.35225556 |
| 75 | neuronal stem cell maintenance (GO:0097150) | 2.34522813 |
| 76 | macroautophagy (GO:0016236) | 2.33159754 |
| 77 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.32864029 |
| 78 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.32864029 |
| 79 | modulation by symbiont of host immune response (GO:0052553) | 2.32864029 |
| 80 | positive regulation by symbiont of host defense response (GO:0052509) | 2.32864029 |
| 81 | modulation by symbiont of host defense response (GO:0052031) | 2.32864029 |
| 82 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.32864029 |
| 83 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.32791280 |
| 84 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.32650183 |
| 85 | nonmotile primary cilium assembly (GO:0035058) | 2.31592380 |
| 86 | dendrite morphogenesis (GO:0048813) | 2.31168210 |
| 87 | axonal fasciculation (GO:0007413) | 2.30687570 |
| 88 | detection of molecule of bacterial origin (GO:0032490) | 2.30259731 |
| 89 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.28256006 |
| 90 | negative chemotaxis (GO:0050919) | 2.27818330 |
| 91 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.27792436 |
| 92 | nucleobase catabolic process (GO:0046113) | 2.26822711 |
| 93 | lymph vessel development (GO:0001945) | 2.26433901 |
| 94 | regulation of axon guidance (GO:1902667) | 2.25419517 |
| 95 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.25344960 |
| 96 | chondrocyte proliferation (GO:0035988) | 2.25241098 |
| 97 | endosome to pigment granule transport (GO:0043485) | 2.25221680 |
| 98 | endosome to melanosome transport (GO:0035646) | 2.25221680 |
| 99 | regulation of oligodendrocyte differentiation (GO:0048713) | 2.24371728 |
| 100 | central nervous system neuron axonogenesis (GO:0021955) | 2.24263872 |
| 101 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.23664159 |
| 102 | regulation of fibroblast apoptotic process (GO:2000269) | 2.23524722 |
| 103 | otic vesicle formation (GO:0030916) | 2.23173200 |
| 104 | myelin assembly (GO:0032288) | 2.23155030 |
| 105 | regulation of protein polyubiquitination (GO:1902914) | 2.22472564 |
| 106 | urinary tract smooth muscle contraction (GO:0014848) | 2.22428868 |
| 107 | protein localization to endosome (GO:0036010) | 2.22098717 |
| 108 | pigment cell differentiation (GO:0050931) | 2.21967288 |
| 109 | glutamate receptor signaling pathway (GO:0007215) | 2.21829360 |
| 110 | cilium movement (GO:0003341) | 2.21467621 |
| 111 | cyclic nucleotide catabolic process (GO:0009214) | 2.19678044 |
| 112 | appendage development (GO:0048736) | 2.19256331 |
| 113 | limb development (GO:0060173) | 2.19256331 |
| 114 | smoothened signaling pathway (GO:0007224) | 2.19198007 |
| 115 | retinal rod cell development (GO:0046548) | 2.19179368 |
| 116 | cellular response to cholesterol (GO:0071397) | 2.17941865 |
| 117 | cAMP catabolic process (GO:0006198) | 2.17756917 |
| 118 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.17446294 |
| 119 | lung lobe morphogenesis (GO:0060463) | 2.17221437 |
| 120 | import into cell (GO:0098657) | 2.17072600 |
| 121 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.16961541 |
| 122 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.16733382 |
| 123 | positive regulation of developmental pigmentation (GO:0048087) | 2.15672098 |
| 124 | extracellular matrix assembly (GO:0085029) | 2.15620156 |
| 125 | negative regulation of sodium ion transport (GO:0010766) | 2.15249089 |
| 126 | regulation of energy homeostasis (GO:2000505) | 2.14335371 |
| 127 | negative regulation of neurotransmitter transport (GO:0051589) | 2.12291891 |
| 128 | positive regulation of osteoblast proliferation (GO:0033690) | 2.12039147 |
| 129 | epithelial cilium movement (GO:0003351) | 2.11564847 |
| 130 | glycolipid catabolic process (GO:0019377) | 2.11553969 |
| 131 | osteoclast differentiation (GO:0030316) | 2.11063384 |
| 132 | positive regulation of muscle hypertrophy (GO:0014742) | 2.10875383 |
| 133 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.10875383 |
| 134 | cellular component assembly involved in morphogenesis (GO:0010927) | 2.10869517 |
| 135 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.10164470 |
| 136 | myelin maintenance (GO:0043217) | 2.09802842 |
| 137 | glycoprotein catabolic process (GO:0006516) | 2.09708753 |
| 138 | response to cholesterol (GO:0070723) | 2.09423825 |
| 139 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.09016600 |
| 140 | retinal cone cell development (GO:0046549) | 2.08751851 |
| 141 | pancreas development (GO:0031016) | 2.08625044 |
| 142 | negative regulation of anoikis (GO:2000811) | 2.06930861 |
| 143 | growth hormone receptor signaling pathway (GO:0060396) | 2.06475792 |
| 144 | regulation of osteoblast proliferation (GO:0033688) | 2.04726377 |
| 145 | glomerular visceral epithelial cell development (GO:0072015) | 2.03961850 |
| 146 | regulation of pigment cell differentiation (GO:0050932) | 2.03393812 |
| 147 | axon extension involved in axon guidance (GO:0048846) | 2.03368649 |
| 148 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.03368649 |
| 149 | Golgi to endosome transport (GO:0006895) | 2.03111291 |
| 150 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.02899626 |
| 151 | apical protein localization (GO:0045176) | 2.01100194 |
| 152 | vesicle fusion (GO:0006906) | 2.00828943 |
| 153 | myelination (GO:0042552) | 1.99997097 |
| 154 | cellular response to vitamin D (GO:0071305) | 1.98792651 |
| 155 | ensheathment of neurons (GO:0007272) | 1.98470359 |
| 156 | axon ensheathment (GO:0008366) | 1.98470359 |
| 157 | apoptotic cell clearance (GO:0043277) | 1.97994463 |
| 158 | mesodermal cell differentiation (GO:0048333) | 1.97827371 |
| 159 | adhesion of symbiont to host cell (GO:0044650) | 1.96945153 |
| 160 | virion attachment to host cell (GO:0019062) | 1.96945153 |
| 161 | positive regulation of actin filament depolymerization (GO:0030836) | 1.96887273 |
| 162 | artery development (GO:0060840) | 1.96637064 |
| 163 | protein localization to cell surface (GO:0034394) | 1.95560088 |
| 164 | cellular response to vitamin (GO:0071295) | 1.95081194 |
| 165 | negative regulation of osteoclast differentiation (GO:0045671) | 1.93604299 |
| 166 | sequestering of extracellular ligand from receptor (GO:0035581) | 1.93431800 |
| 167 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 1.92090475 |
| 168 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 1.90453857 |
| 169 | cellular response to interferon-alpha (GO:0035457) | 1.89639110 |
| 170 | endothelial cell morphogenesis (GO:0001886) | 1.89489955 |
| 171 | wound healing, spreading of cells (GO:0044319) | 1.89172424 |
| 172 | hippo signaling (GO:0035329) | 1.88947758 |
| 173 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 1.88554401 |
| 174 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 1.87508736 |
| 175 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 1.86892341 |
| 176 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 1.85585442 |
| 177 | positive regulation of bone mineralization (GO:0030501) | 1.85484050 |
| 178 | vascular smooth muscle contraction (GO:0014829) | 1.85399289 |
| 179 | substrate-dependent cell migration (GO:0006929) | 1.84820331 |
| 180 | lateral sprouting from an epithelium (GO:0060601) | 1.83569574 |
| 181 | microglial cell activation (GO:0001774) | 1.83216476 |
| 182 | presynaptic membrane assembly (GO:0097105) | 1.83202602 |
| 183 | regulation of smooth muscle cell migration (GO:0014910) | 1.82802096 |
| 184 | lung alveolus development (GO:0048286) | 1.82504024 |
| 185 | cellular response to growth hormone stimulus (GO:0071378) | 1.81997671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 3.03177063 |
| 2 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.52102083 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.40587600 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.37395628 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.37300922 |
| 6 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.27091296 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.10636800 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.09008988 |
| 9 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.08373089 |
| 10 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.08373089 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.07694900 |
| 12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.03043521 |
| 13 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.94701371 |
| 14 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.93448074 |
| 15 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.92656072 |
| 16 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.89512329 |
| 17 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.88630863 |
| 18 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.87524637 |
| 19 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.84274794 |
| 20 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.80181736 |
| 21 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.78407865 |
| 22 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.74987984 |
| 23 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.72917322 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.71639340 |
| 25 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.70426377 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.69126067 |
| 27 | P300_19829295_ChIP-Seq_ESCs_Human | 1.67258556 |
| 28 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.65732295 |
| 29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.65151759 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.62585641 |
| 31 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.60503329 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.60412813 |
| 33 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.59650416 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59189252 |
| 35 | TP53_16413492_ChIP-PET_HCT116_Human | 1.59113248 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57270375 |
| 37 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.56225922 |
| 38 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.56225922 |
| 39 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.54847317 |
| 40 | FUS_26573619_Chip-Seq_HEK293_Human | 1.53011551 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.51529193 |
| 42 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.48525915 |
| 43 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.44892014 |
| 44 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.44740635 |
| 45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42815765 |
| 46 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.41979554 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39631351 |
| 48 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.38503021 |
| 49 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.37829042 |
| 50 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.37323847 |
| 51 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.36872049 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36460925 |
| 53 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.34639994 |
| 54 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.33442035 |
| 55 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.33063695 |
| 56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31979896 |
| 57 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.31203429 |
| 58 | STAT3_23295773_ChIP-Seq_U87_Human | 1.31060801 |
| 59 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.30630767 |
| 60 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.30258417 |
| 61 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.30062018 |
| 62 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.28548005 |
| 63 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.28548005 |
| 64 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.28164559 |
| 65 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.27626622 |
| 66 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.27578042 |
| 67 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27241809 |
| 68 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.26198927 |
| 69 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25567579 |
| 70 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23961829 |
| 71 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22843840 |
| 72 | KDM2B_26808549_Chip-Seq_REH_Human | 1.22118797 |
| 73 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.22063664 |
| 74 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.21434559 |
| 75 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21024048 |
| 76 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.19991062 |
| 77 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.19831285 |
| 78 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.19632053 |
| 79 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.18252686 |
| 80 | TCF4_23295773_ChIP-Seq_U87_Human | 1.18027093 |
| 81 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17576379 |
| 82 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.16527381 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14850037 |
| 84 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.14562029 |
| 85 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14407948 |
| 86 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.13435810 |
| 87 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.13266164 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12582065 |
| 89 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.12578211 |
| 90 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.12417475 |
| 91 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.12142726 |
| 92 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.12129463 |
| 93 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.11785303 |
| 94 | RXR_22108803_ChIP-Seq_LS180_Human | 1.11682547 |
| 95 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11078832 |
| 96 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.11070711 |
| 97 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.10235547 |
| 98 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09936456 |
| 99 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09841781 |
| 100 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.09836370 |
| 101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09653909 |
| 102 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09383654 |
| 103 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.09035966 |
| 104 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08663758 |
| 105 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.08615603 |
| 106 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07906805 |
| 107 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.07632097 |
| 108 | EWS_26573619_Chip-Seq_HEK293_Human | 1.07297890 |
| 109 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.07017116 |
| 110 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.06929071 |
| 111 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.06844410 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06551623 |
| 113 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.06542524 |
| 114 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06472218 |
| 115 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06224698 |
| 116 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.05904563 |
| 117 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.05872266 |
| 118 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05335119 |
| 119 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.05163774 |
| 120 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.05163774 |
| 121 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.04287981 |
| 122 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.03652622 |
| 123 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.03397468 |
| 124 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.03049079 |
| 125 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.03033266 |
| 126 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.02590634 |
| 127 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02543559 |
| 128 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02455835 |
| 129 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01939484 |
| 130 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.01913287 |
| 131 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.00967515 |
| 132 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00054095 |
| 133 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97208004 |
| 134 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97156193 |
| 135 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.96870696 |
| 136 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96107703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.48213857 |
| 2 | MP0003136_yellow_coat_color | 4.24478830 |
| 3 | MP0005503_abnormal_tendon_morphology | 3.70863115 |
| 4 | MP0003950_abnormal_plasma_membrane | 3.53049394 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 3.30771714 |
| 6 | MP0009780_abnormal_chondrocyte_physiolo | 3.14206892 |
| 7 | MP0005171_absent_coat_pigmentation | 3.00323453 |
| 8 | MP0005275_abnormal_skin_tensile | 2.93821520 |
| 9 | MP0000372_irregular_coat_pigmentation | 2.81199630 |
| 10 | MP0000569_abnormal_digit_pigmentation | 2.73892424 |
| 11 | MP0001299_abnormal_eye_distance/ | 2.47105361 |
| 12 | MP0003890_abnormal_embryonic-extraembry | 2.40510912 |
| 13 | MP0004272_abnormal_basement_membrane | 2.33694024 |
| 14 | MP0005174_abnormal_tail_pigmentation | 2.29557634 |
| 15 | MP0005167_abnormal_blood-brain_barrier | 2.22543243 |
| 16 | MP0000371_diluted_coat_color | 2.13990273 |
| 17 | MP0001324_abnormal_eye_pigmentation | 2.12664994 |
| 18 | MP0005058_abnormal_lysosome_morphology | 1.97604729 |
| 19 | MP0003279_aneurysm | 1.91582683 |
| 20 | MP0001984_abnormal_olfaction | 1.90444245 |
| 21 | MP0001879_abnormal_lymphatic_vessel | 1.89636728 |
| 22 | MP0003632_abnormal_nervous_system | 1.88690910 |
| 23 | MP0000920_abnormal_myelination | 1.88350775 |
| 24 | MP0002653_abnormal_ependyma_morphology | 1.87819122 |
| 25 | MP0005623_abnormal_meninges_morphology | 1.86493346 |
| 26 | MP0010678_abnormal_skin_adnexa | 1.86309512 |
| 27 | MP0004134_abnormal_chest_morphology | 1.84749130 |
| 28 | MP0003195_calcinosis | 1.82322326 |
| 29 | MP0009250_abnormal_appendicular_skeleto | 1.81036796 |
| 30 | MP0009384_cardiac_valve_regurgitation | 1.79912442 |
| 31 | MP0005408_hypopigmentation | 1.79214640 |
| 32 | MP0006054_spinal_hemorrhage | 1.74556531 |
| 33 | MP0001958_emphysema | 1.73020715 |
| 34 | MP0004742_abnormal_vestibular_system | 1.69082353 |
| 35 | MP0009046_muscle_twitch | 1.67627436 |
| 36 | MP0000013_abnormal_adipose_tissue | 1.67584879 |
| 37 | MP0004885_abnormal_endolymph | 1.67396058 |
| 38 | MP0002095_abnormal_skin_pigmentation | 1.67129129 |
| 39 | MP0000604_amyloidosis | 1.62971773 |
| 40 | MP0003880_abnormal_central_pattern | 1.60260600 |
| 41 | MP0001486_abnormal_startle_reflex | 1.58898244 |
| 42 | MP0003091_abnormal_cell_migration | 1.53215018 |
| 43 | MP0002282_abnormal_trachea_morphology | 1.52830854 |
| 44 | MP0002896_abnormal_bone_mineralization | 1.51698187 |
| 45 | MP0002009_preneoplasia | 1.49906348 |
| 46 | MP0010386_abnormal_urinary_bladder | 1.49178805 |
| 47 | MP0002295_abnormal_pulmonary_circulatio | 1.48880860 |
| 48 | MP0000015_abnormal_ear_pigmentation | 1.48052925 |
| 49 | MP0002102_abnormal_ear_morphology | 1.47128112 |
| 50 | MP0002837_dystrophic_cardiac_calcinosis | 1.44236277 |
| 51 | MP0003690_abnormal_glial_cell | 1.42760859 |
| 52 | MP0003787_abnormal_imprinting | 1.35101162 |
| 53 | MP0009697_abnormal_copulation | 1.34971462 |
| 54 | MP0004147_increased_porphyrin_level | 1.33321751 |
| 55 | MP0002735_abnormal_chemical_nociception | 1.30932426 |
| 56 | MP0005248_abnormal_Harderian_gland | 1.29752419 |
| 57 | MP0002933_joint_inflammation | 1.28694879 |
| 58 | MP0003937_abnormal_limbs/digits/tail_de | 1.28679357 |
| 59 | MP0005646_abnormal_pituitary_gland | 1.27310621 |
| 60 | MP0003566_abnormal_cell_adhesion | 1.26525818 |
| 61 | MP0002108_abnormal_muscle_morphology | 1.25398941 |
| 62 | MP0003633_abnormal_nervous_system | 1.23586610 |
| 63 | MP0002075_abnormal_coat/hair_pigmentati | 1.22178618 |
| 64 | MP0004084_abnormal_cardiac_muscle | 1.22055091 |
| 65 | MP0002115_abnormal_skeleton_extremities | 1.21692222 |
| 66 | MP0006082_CNS_inflammation | 1.21440650 |
| 67 | MP0004036_abnormal_muscle_relaxation | 1.20819052 |
| 68 | MP0003631_nervous_system_phenotype | 1.19658405 |
| 69 | MP0002638_abnormal_pupillary_reflex | 1.18393084 |
| 70 | MP0003828_pulmonary_edema | 1.18381032 |
| 71 | MP0000383_abnormal_hair_follicle | 1.17808073 |
| 72 | MP0000733_abnormal_muscle_development | 1.16650283 |
| 73 | MP0003385_abnormal_body_wall | 1.14512577 |
| 74 | MP0003634_abnormal_glial_cell | 1.14164274 |
| 75 | MP0005195_abnormal_posterior_eye | 1.12994469 |
| 76 | MP0005257_abnormal_intraocular_pressure | 1.10986365 |
| 77 | MP0003705_abnormal_hypodermis_morpholog | 1.08341153 |
| 78 | MP0003122_maternal_imprinting | 1.07923577 |
| 79 | MP0000516_abnormal_urinary_system | 1.06556780 |
| 80 | MP0005367_renal/urinary_system_phenotyp | 1.06556780 |
| 81 | MP0005508_abnormal_skeleton_morphology | 1.05865179 |
| 82 | MP0005388_respiratory_system_phenotype | 1.05649822 |
| 83 | MP0002133_abnormal_respiratory_system | 1.05649822 |
| 84 | MP0003045_fibrosis | 1.05569028 |
| 85 | MP0002064_seizures | 1.05108060 |
| 86 | MP0002090_abnormal_vision | 1.04177031 |
| 87 | MP0000955_abnormal_spinal_cord | 1.03637372 |
| 88 | MP0009764_decreased_sensitivity_to | 1.02031186 |
| 89 | MP0005409_darkened_coat_color | 1.00861809 |
| 90 | MP0002060_abnormal_skin_morphology | 1.00846528 |
| 91 | MP0003172_abnormal_lysosome_physiology | 1.00205404 |
| 92 | MP0002067_abnormal_sensory_capabilities | 0.99870635 |
| 93 | MP0001485_abnormal_pinna_reflex | 0.99838043 |
| 94 | MP0005391_vision/eye_phenotype | 0.99243923 |
| 95 | MP0002972_abnormal_cardiac_muscle | 0.98821087 |
| 96 | MP0002233_abnormal_nose_morphology | 0.98499446 |
| 97 | MP0010368_abnormal_lymphatic_system | 0.98422803 |
| 98 | MP0006072_abnormal_retinal_apoptosis | 0.98213946 |
| 99 | MP0002998_abnormal_bone_remodeling | 0.98129129 |
| 100 | MP0000428_abnormal_craniofacial_morphol | 0.97856899 |
| 101 | MP0000163_abnormal_cartilage_morphology | 0.97645006 |
| 102 | MP0003329_amyloid_beta_deposits | 0.97317757 |
| 103 | MP0001186_pigmentation_phenotype | 0.97231286 |
| 104 | MP0000566_synostosis | 0.97106754 |
| 105 | MP0002229_neurodegeneration | 0.95890098 |
| 106 | MP0005253_abnormal_eye_physiology | 0.95585698 |
| 107 | MP0002166_altered_tumor_susceptibility | 0.94937965 |
| 108 | MP0008877_abnormal_DNA_methylation | 0.93350026 |
| 109 | MP0005076_abnormal_cell_differentiation | 0.92302796 |
| 110 | MP0002109_abnormal_limb_morphology | 0.92195464 |
| 111 | MP0001177_atelectasis | 0.91815416 |
| 112 | MP0004924_abnormal_behavior | 0.88164972 |
| 113 | MP0005386_behavior/neurological_phenoty | 0.88164972 |
| 114 | MP0000767_abnormal_smooth_muscle | 0.86993066 |
| 115 | MP0000647_abnormal_sebaceous_gland | 0.86846752 |
| 116 | MP0005075_abnormal_melanosome_morpholog | 0.86442077 |
| 117 | MP0004133_heterotaxia | 0.86375109 |
| 118 | MP0003283_abnormal_digestive_organ | 0.86367723 |
| 119 | MP0005164_abnormal_response_to | 0.86213788 |
| 120 | MP0003755_abnormal_palate_morphology | 0.85535892 |
| 121 | MP0004484_altered_response_of | 0.85104886 |
| 122 | MP0005197_abnormal_uvea_morphology | 0.84685919 |
| 123 | MP0001293_anophthalmia | 0.84674664 |
| 124 | MP0002938_white_spotting | 0.84436931 |
| 125 | MP0001340_abnormal_eyelid_morphology | 0.83100782 |
| 126 | MP0002572_abnormal_emotion/affect_behav | 0.82810848 |
| 127 | MP0004142_abnormal_muscle_tone | 0.82546350 |
| 128 | MP0000003_abnormal_adipose_tissue | 0.81302105 |
| 129 | MP0008775_abnormal_heart_ventricle | 0.80736094 |
| 130 | MP0001440_abnormal_grooming_behavior | 0.80451415 |
| 131 | MP0004043_abnormal_pH_regulation | 0.80094691 |
| 132 | MP0004510_myositis | 0.80068264 |
| 133 | MP0005187_abnormal_penis_morphology | 0.80058475 |
| 134 | MP0004215_abnormal_myocardial_fiber | 0.80011461 |
| 135 | MP0010352_gastrointestinal_tract_polyps | 0.79211332 |
| 136 | MP0002113_abnormal_skeleton_development | 0.78953570 |
| 137 | MP0000465_gastrointestinal_hemorrhage | 0.78757936 |
| 138 | MP0009745_abnormal_behavioral_response | 0.78319905 |
| 139 | MP0002272_abnormal_nervous_system | 0.78252565 |
| 140 | MP0009840_abnormal_foam_cell | 0.77595270 |
| 141 | MP0000778_abnormal_nervous_system | 0.77022647 |
| 142 | MP0004270_analgesia | 0.76269234 |
| 143 | MP0004883_abnormal_blood_vessel | 0.76149494 |
| 144 | MP0002752_abnormal_somatic_nervous | 0.75891145 |
| 145 | MP0008057_abnormal_DNA_replication | 0.75570140 |
| 146 | MP0002882_abnormal_neuron_morphology | 0.75247415 |
| 147 | MP0000432_abnormal_head_morphology | 0.73563895 |
| 148 | MP0005390_skeleton_phenotype | 0.73080016 |
| 149 | MP0000427_abnormal_hair_cycle | 0.72818947 |
| 150 | MP0002063_abnormal_learning/memory/cond | 0.72750888 |
| 151 | MP0002177_abnormal_outer_ear | 0.71870775 |
| 152 | MP0002734_abnormal_mechanical_nocicepti | 0.71525140 |
| 153 | MP0002928_abnormal_bile_duct | 0.71175928 |
| 154 | MP0003795_abnormal_bone_structure | 0.70786990 |
| 155 | MP0005620_abnormal_muscle_contractility | 0.70188509 |
| 156 | MP0001533_abnormal_skeleton_physiology | 0.68926876 |
| 157 | MP0002234_abnormal_pharynx_morphology | 0.68552200 |
| 158 | MP0003935_abnormal_craniofacial_develop | 0.67787831 |
| 159 | MP0002751_abnormal_autonomic_nervous | 0.67617560 |
| 160 | MP0003121_genomic_imprinting | 0.67423207 |
| 161 | MP0005551_abnormal_eye_electrophysiolog | 0.67232551 |
| 162 | MP0005595_abnormal_vascular_smooth | 0.67163378 |
| 163 | MP0000534_abnormal_ureter_morphology | 0.67077224 |
| 164 | MP0004185_abnormal_adipocyte_glucose | 0.64393124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperventilation (HP:0002883) | 4.53493682 |
| 2 | Arterial tortuosity (HP:0005116) | 4.19089179 |
| 3 | Vascular tortuosity (HP:0004948) | 3.97521039 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.97230576 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.97230576 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 3.97230576 |
| 7 | Pancreatic fibrosis (HP:0100732) | 3.58607880 |
| 8 | Abnormality of midbrain morphology (HP:0002418) | 3.52415767 |
| 9 | Molar tooth sign on MRI (HP:0002419) | 3.52415767 |
| 10 | True hermaphroditism (HP:0010459) | 3.52219745 |
| 11 | Pancreatic cysts (HP:0001737) | 3.46727927 |
| 12 | Epiphyseal dysplasia (HP:0002656) | 3.19604571 |
| 13 | Neurofibrillary tangles (HP:0002185) | 3.05280623 |
| 14 | Premature rupture of membranes (HP:0001788) | 2.97526643 |
| 15 | Inappropriate behavior (HP:0000719) | 2.94527395 |
| 16 | Subacute progressive viral hepatitis (HP:0006572) | 2.87794939 |
| 17 | Hypoplastic ischia (HP:0003175) | 2.83036127 |
| 18 | Absent speech (HP:0001344) | 2.82933738 |
| 19 | Hypokalemic alkalosis (HP:0001949) | 2.81067626 |
| 20 | Aortic aneurysm (HP:0004942) | 2.75466097 |
| 21 | Increased circulating renin level (HP:0000848) | 2.69478484 |
| 22 | Medial flaring of the eyebrow (HP:0010747) | 2.66700453 |
| 23 | Aortic dissection (HP:0002647) | 2.66453432 |
| 24 | Blue irides (HP:0000635) | 2.66225223 |
| 25 | Abnormality of the ischium (HP:0003174) | 2.65096732 |
| 26 | Nephronophthisis (HP:0000090) | 2.63457191 |
| 27 | Gait imbalance (HP:0002141) | 2.56808187 |
| 28 | Genital tract atresia (HP:0001827) | 2.56681904 |
| 29 | Vaginal atresia (HP:0000148) | 2.56317885 |
| 30 | Tubulointerstitial fibrosis (HP:0005576) | 2.52664779 |
| 31 | Broad ribs (HP:0000885) | 2.52170606 |
| 32 | Hematochezia (HP:0002573) | 2.51038976 |
| 33 | Absent frontal sinuses (HP:0002688) | 2.47292869 |
| 34 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.46911828 |
| 35 | Congenital primary aphakia (HP:0007707) | 2.46890985 |
| 36 | Congenital hepatic fibrosis (HP:0002612) | 2.45555793 |
| 37 | Febrile seizures (HP:0002373) | 2.40321520 |
| 38 | Cone-rod dystrophy (HP:0000548) | 2.38879764 |
| 39 | Abnormality of the renal medulla (HP:0100957) | 2.38324485 |
| 40 | Drooling (HP:0002307) | 2.37618895 |
| 41 | Fair hair (HP:0002286) | 2.35191252 |
| 42 | Tubular atrophy (HP:0000092) | 2.33662343 |
| 43 | Polyuria (HP:0000103) | 2.31914732 |
| 44 | Metabolic alkalosis (HP:0200114) | 2.31686410 |
| 45 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.31277512 |
| 46 | Abnormal ciliary motility (HP:0012262) | 2.30890005 |
| 47 | Submucous cleft hard palate (HP:0000176) | 2.29544469 |
| 48 | Metaphyseal dysplasia (HP:0100255) | 2.29054399 |
| 49 | Abnormality of incisor morphology (HP:0011063) | 2.28901419 |
| 50 | Generalized hypopigmentation of hair (HP:0011358) | 2.27168092 |
| 51 | Widely spaced teeth (HP:0000687) | 2.26892623 |
| 52 | Fibular hypoplasia (HP:0003038) | 2.26533822 |
| 53 | Abnormality of the nasal septum (HP:0000419) | 2.24897730 |
| 54 | Cerebral inclusion bodies (HP:0100314) | 2.24392683 |
| 55 | Abnormality of the frontal sinuses (HP:0002687) | 2.24390663 |
| 56 | Nephrogenic diabetes insipidus (HP:0009806) | 2.21598095 |
| 57 | Macroorchidism (HP:0000053) | 2.20858665 |
| 58 | Abnormal drinking behavior (HP:0030082) | 2.20570401 |
| 59 | Polydipsia (HP:0001959) | 2.20570401 |
| 60 | Overgrowth (HP:0001548) | 2.19586974 |
| 61 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.19339990 |
| 62 | Hypoplasia of the fovea (HP:0007750) | 2.19339990 |
| 63 | Spondylolisthesis (HP:0003302) | 2.17630888 |
| 64 | Pulmonary artery stenosis (HP:0004415) | 2.17472191 |
| 65 | Epidermoid cyst (HP:0200040) | 2.17356564 |
| 66 | Postaxial foot polydactyly (HP:0001830) | 2.16815886 |
| 67 | Cystic liver disease (HP:0006706) | 2.16172001 |
| 68 | Excessive salivation (HP:0003781) | 2.15019458 |
| 69 | Vacuolated lymphocytes (HP:0001922) | 2.11224076 |
| 70 | Action tremor (HP:0002345) | 2.09884611 |
| 71 | Protruding tongue (HP:0010808) | 2.09415686 |
| 72 | Hyperactive renin-angiotensin system (HP:0000841) | 2.08739979 |
| 73 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.08556926 |
| 74 | Abnormality of the renal cortex (HP:0011035) | 2.08539426 |
| 75 | Disinhibition (HP:0000734) | 2.08498106 |
| 76 | Anencephaly (HP:0002323) | 2.08035490 |
| 77 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.07773644 |
| 78 | Decreased lacrimation (HP:0000633) | 2.06674061 |
| 79 | Hypoplasia of the iris (HP:0007676) | 2.04278755 |
| 80 | Abnormality of the right ventricle (HP:0001707) | 2.03975390 |
| 81 | Abnormality of the fovea (HP:0000493) | 2.03393297 |
| 82 | Mixed hearing impairment (HP:0000410) | 2.03239231 |
| 83 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.02802454 |
| 84 | Absent/shortened dynein arms (HP:0200106) | 2.02802454 |
| 85 | Progressive cerebellar ataxia (HP:0002073) | 2.02547550 |
| 86 | Increased cerebral lipofuscin (HP:0011813) | 2.02463632 |
| 87 | Tubulointerstitial abnormality (HP:0001969) | 2.02105610 |
| 88 | Chronic hepatic failure (HP:0100626) | 2.01592051 |
| 89 | Occipital encephalocele (HP:0002085) | 2.00309729 |
| 90 | Papillary thyroid carcinoma (HP:0002895) | 1.99715013 |
| 91 | Hypoplastic pelvis (HP:0008839) | 1.99708887 |
| 92 | Atonic seizures (HP:0010819) | 1.99522408 |
| 93 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.98157305 |
| 94 | Hyperaldosteronism (HP:0000859) | 1.98102304 |
| 95 | Abnormal auditory evoked potentials (HP:0006958) | 1.96137149 |
| 96 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.94885740 |
| 97 | Scapular winging (HP:0003691) | 1.93585046 |
| 98 | Soft skin (HP:0000977) | 1.92800374 |
| 99 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.90638473 |
| 100 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.90638473 |
| 101 | Asymmetry of the thorax (HP:0001555) | 1.88999009 |
| 102 | Vitreoretinal degeneration (HP:0000655) | 1.87480796 |
| 103 | Poor coordination (HP:0002370) | 1.87307315 |
| 104 | Limited elbow extension (HP:0001377) | 1.87060984 |
| 105 | Rhinitis (HP:0012384) | 1.84758086 |
| 106 | Neonatal short-limb short stature (HP:0008921) | 1.84543125 |
| 107 | Aplasia involving bones of the extremities (HP:0009825) | 1.83936697 |
| 108 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.83936697 |
| 109 | Aplasia of the phalanges of the hand (HP:0009802) | 1.83936697 |
| 110 | Short nail (HP:0001799) | 1.83784701 |
| 111 | Cerebral aneurysm (HP:0004944) | 1.83778133 |
| 112 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.82918142 |
| 113 | Cupped ear (HP:0000378) | 1.82620415 |
| 114 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.82052670 |
| 115 | Femoral bowing (HP:0002980) | 1.81651216 |
| 116 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.81567394 |
| 117 | Insidious onset (HP:0003587) | 1.81231745 |
| 118 | Termporal pattern (HP:0011008) | 1.81231745 |
| 119 | Cervical subluxation (HP:0003308) | 1.80891212 |
| 120 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.80675023 |
| 121 | Bell-shaped thorax (HP:0001591) | 1.80315237 |
| 122 | Postaxial hand polydactyly (HP:0001162) | 1.80136848 |
| 123 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.80073726 |
| 124 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.80073726 |
| 125 | Abnormal urine output (HP:0012590) | 1.80008784 |
| 126 | Shallow orbits (HP:0000586) | 1.79449399 |
| 127 | Hepatoblastoma (HP:0002884) | 1.79050646 |
| 128 | Protrusio acetabuli (HP:0003179) | 1.78303539 |
| 129 | Sclerocornea (HP:0000647) | 1.78208471 |
| 130 | Agnosia (HP:0010524) | 1.77704950 |
| 131 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.76889424 |
| 132 | Osteolytic defects of the hand bones (HP:0009699) | 1.76889424 |
| 133 | Global brain atrophy (HP:0002283) | 1.76855767 |
| 134 | Wormian bones (HP:0002645) | 1.76678064 |
| 135 | Alacrima (HP:0000522) | 1.76006516 |
| 136 | Cranial hyperostosis (HP:0004437) | 1.75659852 |
| 137 | Natal tooth (HP:0000695) | 1.75580645 |
| 138 | Exostoses (HP:0100777) | 1.74907242 |
| 139 | Volvulus (HP:0002580) | 1.74038429 |
| 140 | Short 4th metacarpal (HP:0010044) | 1.73170408 |
| 141 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.73170408 |
| 142 | Limited hip movement (HP:0008800) | 1.72931408 |
| 143 | Hypoplastic labia majora (HP:0000059) | 1.72664096 |
| 144 | Congenital sensorineural hearing impairment (HP:0008527) | 1.72595961 |
| 145 | Gaze-evoked nystagmus (HP:0000640) | 1.71992779 |
| 146 | Oculomotor apraxia (HP:0000657) | 1.71118495 |
| 147 | Short foot (HP:0001773) | 1.71087679 |
| 148 | Buphthalmos (HP:0000557) | 1.70818177 |
| 149 | Narrow palate (HP:0000189) | 1.70421475 |
| 150 | Aqueductal stenosis (HP:0002410) | 1.70136821 |
| 151 | Furrowed tongue (HP:0000221) | 1.69479296 |
| 152 | Small epiphyses (HP:0010585) | 1.69163229 |
| 153 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.68921406 |
| 154 | Albinism (HP:0001022) | 1.68865301 |
| 155 | Narrow forehead (HP:0000341) | 1.68539010 |
| 156 | Mitral valve prolapse (HP:0001634) | 1.68418063 |
| 157 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.68389694 |
| 158 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.68243647 |
| 159 | Retinal atrophy (HP:0001105) | 1.67971394 |
| 160 | Abnormality of the fibula (HP:0002991) | 1.67695528 |
| 161 | Cupped ribs (HP:0000887) | 1.67150491 |
| 162 | Abolished electroretinogram (ERG) (HP:0000550) | 1.65775935 |
| 163 | Abnormality of chloride homeostasis (HP:0011422) | 1.65352429 |
| 164 | Abnormal pancreas size (HP:0012094) | 1.65236030 |
| 165 | Type II lissencephaly (HP:0007260) | 1.64911433 |
| 166 | Broad-based gait (HP:0002136) | 1.64183277 |
| 167 | Anophthalmia (HP:0000528) | 1.64087449 |
| 168 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.63796541 |
| 169 | Focal seizures (HP:0007359) | 1.62551780 |
| 170 | Left ventricular hypertrophy (HP:0001712) | 1.62519258 |
| 171 | Joint laxity (HP:0001388) | 1.61388603 |
| 172 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.60590052 |
| 173 | Dilatation of the ascending aorta (HP:0005111) | 1.59320023 |
| 174 | Atrophic scars (HP:0001075) | 1.57841388 |
| 175 | Micronodular cirrhosis (HP:0001413) | 1.56960336 |
| 176 | Abnormality of the 2nd finger (HP:0004100) | 1.55634290 |
| 177 | Craniofacial hyperostosis (HP:0004493) | 1.54532793 |
| 178 | Abnormal foot bone ossification (HP:0010675) | 1.53168810 |
| 179 | Progressive visual loss (HP:0000529) | 1.52840031 |
| 180 | Abnormality of the labia majora (HP:0012881) | 1.52609024 |
| 181 | Follicular hyperkeratosis (HP:0007502) | 1.52385657 |
| 182 | Pectus carinatum (HP:0000768) | 1.51791092 |
| 183 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.51454994 |
| 184 | Abnormality of dentin (HP:0010299) | 1.51264389 |
| 185 | Mild short stature (HP:0003502) | 1.49745692 |
| 186 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.48969996 |
| 187 | Neoplasm of the adrenal cortex (HP:0100641) | 1.48765029 |
| 188 | Short clavicles (HP:0000894) | 1.48586855 |
| 189 | Tarsal synostosis (HP:0008368) | 1.48507332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.82388331 |
| 2 | ACVR1B | 3.70426151 |
| 3 | FGFR2 | 3.13811014 |
| 4 | MET | 2.71309720 |
| 5 | PBK | 2.70310946 |
| 6 | LATS1 | 2.60623900 |
| 7 | PNCK | 2.58469474 |
| 8 | STK39 | 2.48198057 |
| 9 | BCR | 2.37774945 |
| 10 | TNIK | 2.31467686 |
| 11 | NUAK1 | 2.14182161 |
| 12 | MARK1 | 2.05091648 |
| 13 | WNK3 | 1.96347935 |
| 14 | INSRR | 1.93266156 |
| 15 | CAMK1G | 1.82244434 |
| 16 | SIK1 | 1.81981022 |
| 17 | STK3 | 1.74788993 |
| 18 | DDR2 | 1.72691342 |
| 19 | ADRBK2 | 1.72063671 |
| 20 | CAMK1D | 1.69231716 |
| 21 | MST1R | 1.65763278 |
| 22 | PTK6 | 1.65489303 |
| 23 | TTN | 1.60592550 |
| 24 | MST4 | 1.59534312 |
| 25 | MAP3K14 | 1.52419296 |
| 26 | PIK3CA | 1.49897068 |
| 27 | TRPM7 | 1.47560810 |
| 28 | FER | 1.46900861 |
| 29 | WNK4 | 1.43278805 |
| 30 | PINK1 | 1.41946679 |
| 31 | TIE1 | 1.40752559 |
| 32 | NTRK3 | 1.40180544 |
| 33 | MAP4K2 | 1.38672035 |
| 34 | WNK1 | 1.34202409 |
| 35 | PKN1 | 1.32982346 |
| 36 | TGFBR2 | 1.31012449 |
| 37 | TGFBR1 | 1.29385170 |
| 38 | MARK3 | 1.26734714 |
| 39 | ERBB3 | 1.26614741 |
| 40 | PAK3 | 1.26007866 |
| 41 | OXSR1 | 1.25260857 |
| 42 | NTRK2 | 1.23435399 |
| 43 | PDGFRB | 1.22504189 |
| 44 | MAPK15 | 1.19192057 |
| 45 | CSNK1A1L | 1.18883870 |
| 46 | PLK2 | 1.17539268 |
| 47 | AKT3 | 1.15650861 |
| 48 | SGK494 | 1.12903631 |
| 49 | SGK223 | 1.12903631 |
| 50 | PTK2B | 1.11203313 |
| 51 | CAMKK2 | 1.10702559 |
| 52 | EPHA4 | 1.10396672 |
| 53 | NEK6 | 1.10319252 |
| 54 | TRIM28 | 1.08854793 |
| 55 | DAPK2 | 1.06131608 |
| 56 | MKNK2 | 1.04055284 |
| 57 | PDK2 | 1.02971502 |
| 58 | DMPK | 0.98313936 |
| 59 | OBSCN | 0.98233375 |
| 60 | NEK9 | 0.97023344 |
| 61 | JAK1 | 0.96857388 |
| 62 | MAPK13 | 0.96424778 |
| 63 | PDGFRA | 0.94843627 |
| 64 | LIMK1 | 0.93078101 |
| 65 | NLK | 0.91445421 |
| 66 | MATK | 0.90533612 |
| 67 | BMPR1B | 0.85440455 |
| 68 | EPHA3 | 0.84037458 |
| 69 | PRKCE | 0.83754904 |
| 70 | BLK | 0.83193565 |
| 71 | FGFR3 | 0.80676436 |
| 72 | BRD4 | 0.79987611 |
| 73 | MELK | 0.79276941 |
| 74 | STK38L | 0.79076050 |
| 75 | ROCK1 | 0.77682006 |
| 76 | SGK2 | 0.77306502 |
| 77 | MAP3K2 | 0.75857657 |
| 78 | FGFR1 | 0.74835052 |
| 79 | CSNK1G2 | 0.73824058 |
| 80 | SGK3 | 0.73518721 |
| 81 | YES1 | 0.73460113 |
| 82 | ITK | 0.73349314 |
| 83 | CSNK1G1 | 0.71876376 |
| 84 | NTRK1 | 0.71795874 |
| 85 | * INSR | 0.71116796 |
| 86 | KSR1 | 0.70582497 |
| 87 | STK24 | 0.69792824 |
| 88 | MAP2K4 | 0.67546501 |
| 89 | MKNK1 | 0.66683338 |
| 90 | MAP3K4 | 0.66459534 |
| 91 | EPHB2 | 0.65113506 |
| 92 | ERBB2 | 0.63636468 |
| 93 | RET | 0.63590716 |
| 94 | FGR | 0.63421629 |
| 95 | DYRK1A | 0.63256619 |
| 96 | TYRO3 | 0.62670865 |
| 97 | RIPK4 | 0.62581948 |
| 98 | GRK1 | 0.62356471 |
| 99 | IRAK3 | 0.60897398 |
| 100 | PRKCQ | 0.60550325 |
| 101 | PRKAA2 | 0.59584769 |
| 102 | PRKG1 | 0.59221595 |
| 103 | WEE1 | 0.59158677 |
| 104 | IGF1R | 0.58004731 |
| 105 | RIPK1 | 0.56810261 |
| 106 | GRK7 | 0.56800748 |
| 107 | PRKACB | 0.56689666 |
| 108 | PRKD1 | 0.55395122 |
| 109 | SGK1 | 0.55381010 |
| 110 | PTK2 | 0.54856668 |
| 111 | PRKCG | 0.54035796 |
| 112 | BMX | 0.52207818 |
| 113 | CAMK2D | 0.51953119 |
| 114 | CDK6 | 0.51915854 |
| 115 | CASK | 0.51047626 |
| 116 | CAMK2A | 0.49793473 |
| 117 | CDC42BPA | 0.49729545 |
| 118 | BMPR2 | 0.49423920 |
| 119 | GSK3A | 0.49319648 |
| 120 | ZAK | 0.49029496 |
| 121 | ROCK2 | 0.48326667 |
| 122 | RPS6KB1 | 0.47298530 |
| 123 | PRKCH | 0.46611442 |
| 124 | CSK | 0.46506961 |
| 125 | MAP2K7 | 0.46362430 |
| 126 | TYK2 | 0.46163375 |
| 127 | CHUK | 0.45526784 |
| 128 | EGFR | 0.45466438 |
| 129 | STK11 | 0.42981762 |
| 130 | BRSK2 | 0.42460817 |
| 131 | FYN | 0.42109269 |
| 132 | TAOK3 | 0.41804516 |
| 133 | STK10 | 0.41734254 |
| 134 | ABL1 | 0.40878171 |
| 135 | SRC | 0.40592946 |
| 136 | EPHB1 | 0.40556347 |
| 137 | CAMK2B | 0.40396998 |
| 138 | IRAK1 | 0.39395066 |
| 139 | CSNK1G3 | 0.39310970 |
| 140 | CDK3 | 0.39261383 |
| 141 | MAP3K7 | 0.38771503 |
| 142 | IRAK2 | 0.37482135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.11848054 |
| 2 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.84976386 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.81597748 |
| 4 | Histidine metabolism_Homo sapiens_hsa00340 | 1.67488311 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.59083756 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.55262264 |
| 7 | Focal adhesion_Homo sapiens_hsa04510 | 1.53767934 |
| 8 | Malaria_Homo sapiens_hsa05144 | 1.52504207 |
| 9 | Phagosome_Homo sapiens_hsa04145 | 1.48428968 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 1.47688226 |
| 11 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.47261692 |
| 12 | Nicotine addiction_Homo sapiens_hsa05033 | 1.42389907 |
| 13 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.39984315 |
| 14 | ABC transporters_Homo sapiens_hsa02010 | 1.35435763 |
| 15 | Axon guidance_Homo sapiens_hsa04360 | 1.34789057 |
| 16 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.28660724 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27845409 |
| 18 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.27660292 |
| 19 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.26777852 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.26132291 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.25374387 |
| 22 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.24992531 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.24158712 |
| 24 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.23899962 |
| 25 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21841283 |
| 26 | Adherens junction_Homo sapiens_hsa04520 | 1.21510302 |
| 27 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.21166419 |
| 28 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.21166274 |
| 29 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.19475364 |
| 30 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.19285611 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.18755048 |
| 32 | Mineral absorption_Homo sapiens_hsa04978 | 1.17312459 |
| 33 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.16792152 |
| 34 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.13065923 |
| 35 | Renin secretion_Homo sapiens_hsa04924 | 1.12882795 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10904530 |
| 37 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.07871995 |
| 38 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.06942593 |
| 39 | Prostate cancer_Homo sapiens_hsa05215 | 1.00888554 |
| 40 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00604767 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.00592804 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 0.99091755 |
| 43 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.97736880 |
| 44 | Phototransduction_Homo sapiens_hsa04744 | 0.96919707 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.92947196 |
| 46 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.92550249 |
| 47 | Amoebiasis_Homo sapiens_hsa05146 | 0.92000113 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91919465 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91238969 |
| 50 | Melanoma_Homo sapiens_hsa05218 | 0.90666071 |
| 51 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.88862088 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88845476 |
| 53 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.88416431 |
| 54 | Long-term depression_Homo sapiens_hsa04730 | 0.88352584 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88218523 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87873043 |
| 57 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.86490358 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85308505 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85186255 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84555753 |
| 61 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84355428 |
| 62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.84266018 |
| 63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83559486 |
| 64 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.83365709 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.83297734 |
| 66 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.83237090 |
| 67 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.83107474 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82964526 |
| 69 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.82437995 |
| 70 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.81973610 |
| 71 | * TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.81735329 |
| 72 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.80942993 |
| 73 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.80654786 |
| 74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80260044 |
| 75 | * Endocytosis_Homo sapiens_hsa04144 | 0.79057409 |
| 76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78794686 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77729170 |
| 78 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.77320306 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77315768 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76691292 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76554043 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76366592 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.76273875 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.76269053 |
| 85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76182184 |
| 86 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.75859236 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.75667587 |
| 88 | Tuberculosis_Homo sapiens_hsa05152 | 0.75545846 |
| 89 | Circadian entrainment_Homo sapiens_hsa04713 | 0.75372271 |
| 90 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75311368 |
| 91 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.75301430 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74643175 |
| 93 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74423055 |
| 94 | Tight junction_Homo sapiens_hsa04530 | 0.74300578 |
| 95 | Morphine addiction_Homo sapiens_hsa05032 | 0.74204662 |
| 96 | GABAergic synapse_Homo sapiens_hsa04727 | 0.73440361 |
| 97 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73312760 |
| 98 | Cocaine addiction_Homo sapiens_hsa05030 | 0.70814347 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68313873 |
| 100 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.66814461 |
| 101 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66497036 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66396312 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66033228 |
| 104 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66024623 |
| 105 | Salivary secretion_Homo sapiens_hsa04970 | 0.65917966 |
| 106 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.65799068 |
| 107 | Olfactory transduction_Homo sapiens_hsa04740 | 0.65772126 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64901424 |
| 109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64315300 |
| 110 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.63737349 |
| 111 | Pathways in cancer_Homo sapiens_hsa05200 | 0.63580028 |
| 112 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.63347475 |
| 113 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.63343526 |
| 114 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.63198480 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63108777 |
| 116 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62995690 |
| 117 | Insulin secretion_Homo sapiens_hsa04911 | 0.62285499 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | 0.62278341 |
| 119 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62220030 |
| 120 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62042640 |
| 121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61652495 |
| 122 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.61609021 |
| 123 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.61448469 |
| 124 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61433324 |
| 125 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.59705865 |
| 126 | Glioma_Homo sapiens_hsa05214 | 0.59666666 |
| 127 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.58995194 |
| 128 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58827375 |
| 129 | Melanogenesis_Homo sapiens_hsa04916 | 0.58597371 |
| 130 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.57691150 |
| 131 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57603765 |
| 132 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57489049 |
| 133 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57024774 |
| 134 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.56052739 |
| 135 | Pertussis_Homo sapiens_hsa05133 | 0.54852284 |
| 136 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54225601 |
| 137 | Bile secretion_Homo sapiens_hsa04976 | 0.54032143 |
| 138 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.49604649 |
| 139 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48424515 |
| 140 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.47832108 |
| 141 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47386379 |
| 142 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46325035 |

